• Register
  • Login
  • Subscribe
  • Contact Us

Successive Delivery of Reagents Produced by Stemcell Technologies

PolandTenders notice for Successive Delivery of Reagents Produced by Stemcell Technologies. The reference ID of the tender is 56258986 and it is closing on 20 Aug 2021.

Tender Details

  • Country: Poland
  • Summary: Successive Delivery of Reagents Produced by Stemcell Technologies
  • PLT Ref No: 56258986
  • Deadline: 20 Aug 2021
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 2021/BZP 00147052/01
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Trading applies: Public Decision
    Bend type: Deliveries
    KLDKS Description of the subject of the order: 1. The subject of this order is the successive delivery of reagents produced by StemCell Technologies or stewed for organizational units of the Warsaw University of Medical University. 2. A particular description of the order of the order, with a gaining of the type and number of reagents have been specified in the assortment form -Center, which is a start-up No. 2 to the SWZ., 3. The subject of the order, specified in the impact of 2 to SWZ, was made on the basis of analysis of delivering supplies carried out in the last 12 months, taking into account changes in the quantities necessary for the implementation of research programmers, which continues requires the use of reagents of the same producer. 4. The Orderer reserves the right to change the quotation of the subject of grafted declared order as to the type in the assortment form, the provision of No. 2, within the limits of contractual remuneration (4 par. 1 of the contract of contract), as well as the possibility of not using The subject of the contract in Ilic and value range, however, not exceeding 30% of the remuneration of the remuneration specified in the contract. Contractors in this ...
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Successive Delivery of Reagents Produced by Stemcell Technologies - Poland Tender

The WARSAW MEDICAL UNIVERSITY, a Government sector organization in Poland, has announced a new tender for Successive Delivery of Reagents Produced by Stemcell Technologies. This tender is published on PolandTenders under PLT Ref No: 56258986 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-08-20.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

PolandTenders Features

PolandTenders Features

Fresh and verified Tenders from Poland. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting PolandTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Poland in your email inbox.

  Chat with us